Members |
acceptabilityId |
beta-Hydroxybutyrate dehydrogenase measurement (procedure) |
Preferred (foundation metadata concept) |
beta-Ketoglutaric-isocitric carboxylase |
Acceptable (foundation metadata concept) |
beta-Lipoprotein measurement |
Preferred (foundation metadata concept) |
beta-Lipoprotein measurement (procedure) |
Preferred (foundation metadata concept) |
beta-Lipotropin measurement |
Preferred (foundation metadata concept) |
beta-Lipotropin measurement (procedure) |
Preferred (foundation metadata concept) |
beta-Melanocyte stimulating hormone measurement |
Preferred (foundation metadata concept) |
beta-Melanocyte stimulating hormone measurement (procedure) |
Preferred (foundation metadata concept) |
beta-Methylcrotonylglycinuria, type 1 |
Acceptable (foundation metadata concept) |
beta-Sitosterolemia |
Acceptable (foundation metadata concept) |
beta-gamma-Tocopherol measurement |
Preferred (foundation metadata concept) |
beta-gamma-Tocopherol measurement (procedure) |
Preferred (foundation metadata concept) |
beta>2< Glycoprotein |
Preferred (foundation metadata concept) |
beta>2< Glycoprotein (substance) |
Preferred (foundation metadata concept) |
beta^+^ Thalassemia, normal Hb A>2<, type 2 |
Preferred (foundation metadata concept) |
beta^+^ Thalassemia, normal Hb A>2<, type 2 (disorder) |
Preferred (foundation metadata concept) |
bid - Twice a day |
Acceptable (foundation metadata concept) |
bis-(Diethylthiocarbamyl) disulfide |
Preferred (foundation metadata concept) |
bis-(Diethylthiocarbamyl) disulfide (substance) |
Preferred (foundation metadata concept) |
bis-(Dimethylamino)-phosphorous anhydride |
Preferred (foundation metadata concept) |
bis-(Dimethylamino)-phosphorous anhydride (substance) |
Preferred (foundation metadata concept) |
bis-(Dimethylthiocarbamyl) disulfide |
Preferred (foundation metadata concept) |
bis-(Dimethylthiocarbamyl) disulfide (substance) |
Preferred (foundation metadata concept) |
bis-(Isopropylamido) fluorophosphate |
Preferred (foundation metadata concept) |
bis-(Isopropylamido) fluorophosphate (substance) |
Preferred (foundation metadata concept) |
bis-(p-Chlorophenoxy) methane |
Acceptable (foundation metadata concept) |
bis-(p-Chlorophenyl) trichloroethanol |
Acceptable (foundation metadata concept) |
bottles/24h |
Preferred (foundation metadata concept) |
bottles/24h (qualifier value) |
Preferred (foundation metadata concept) |
bottles/day |
Preferred (foundation metadata concept) |
bottles/day (qualifier value) |
Preferred (foundation metadata concept) |
bottles/feed |
Preferred (foundation metadata concept) |
bottles/feed (qualifier value) |
Preferred (foundation metadata concept) |
bottles/meal |
Preferred (foundation metadata concept) |
bottles/meal (qualifier value) |
Preferred (foundation metadata concept) |
breaths per minute |
Acceptable (foundation metadata concept) |
breaths/min |
Preferred (foundation metadata concept) |
c |
Preferred (foundation metadata concept) |
c - Clinical staging |
Acceptable (foundation metadata concept) |
c antigen |
Acceptable (foundation metadata concept) |
c-ALL |
Acceptable (foundation metadata concept) |
c-ALL - Common acute lymphoblastic leukemia antigen |
Acceptable (foundation metadata concept) |
c-ANCA |
Preferred (foundation metadata concept) |
c-ANCA - Classical neutrophil cytoplasmic antibody |
Acceptable (foundation metadata concept) |
c-Antineutrophil cytoplasmic antibody |
Acceptable (foundation metadata concept) |
c-Ros receptor tyrosine kinase |
Acceptable (foundation metadata concept) |
c1 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
c2 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
c5 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
c6 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
c70 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
c71 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
c73 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
c74 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
cAMP - Cyclic adenosine monophosphate |
Acceptable (foundation metadata concept) |
cAMP measurement |
Acceptable (foundation metadata concept) |
cDCD - Controlled donation after cardiocirculatory death |
Acceptable (foundation metadata concept) |
cDCD - Controlled donation after circulatory death |
Preferred (foundation metadata concept) |
cDE genotype |
Preferred (foundation metadata concept) |
cDE genotype (finding) |
Preferred (foundation metadata concept) |
cDE haplotype |
Preferred (foundation metadata concept) |
cDE haplotype (finding) |
Preferred (foundation metadata concept) |
cDNA |
Acceptable (foundation metadata concept) |
cDe genotype |
Preferred (foundation metadata concept) |
cDe genotype (finding) |
Preferred (foundation metadata concept) |
cDe haplotype |
Preferred (foundation metadata concept) |
cDe haplotype (finding) |
Preferred (foundation metadata concept) |
cGy |
Preferred (foundation metadata concept) |
cGy/h |
Preferred (foundation metadata concept) |
cGy/min |
Preferred (foundation metadata concept) |
cL |
Preferred (foundation metadata concept) |
cM category |
Preferred (foundation metadata concept) |
cM category (observable entity) |
Preferred (foundation metadata concept) |
cM0 |
Preferred (foundation metadata concept) |
cM0 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
cM0(i+) |
Preferred (foundation metadata concept) |
cM0(i+) - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
cM1 |
Preferred (foundation metadata concept) |
cM1 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
cM1a |
Preferred (foundation metadata concept) |
cM1a - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
cM1a(0) |
Preferred (foundation metadata concept) |
cM1a(0) - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
cM1a(1) |
Preferred (foundation metadata concept) |
cM1a(1) - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
cM1b |
Preferred (foundation metadata concept) |
cM1b - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
cM1b(0) |
Preferred (foundation metadata concept) |
cM1b(0) - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
cM1b(1) |
Preferred (foundation metadata concept) |
cM1b(1) - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
cM1c |
Preferred (foundation metadata concept) |
cM1c - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
cM1c(0) |
Preferred (foundation metadata concept) |
cM1c(0) - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
cM1c(1) |
Preferred (foundation metadata concept) |
cM1c(1) - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
cM1d |
Preferred (foundation metadata concept) |
cM1d - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
cM1d(0) |
Preferred (foundation metadata concept) |
cM1d(0) - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |